Tenaya Therapeutics, Inc. Earnings Per Share Disclosure
Note 10. Net Loss Per Share
Basic and diluted loss per share are computed by dividing net loss by the weighted-average number of common shares outstanding during the reporting period. Basic weighted-average shares of common stock outstanding includes the weighted-average effect of the Company’s pre-funded warrants.
The following potentially dilutive securities were excluded from the calculation of diluted net loss per share for the periods presented because the effect would have been anti-dilutive:
|
|
December 31, |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
Outstanding stock options and restricted stock units |
|
|
10,608,154 |
|
|
|
9,431,710 |
|
Outstanding Lender Warrant |
|
|
171,848 |
|
|
|
— |
|
Total |
|
|
10,780,002 |
|
|
|
9,431,710 |
|
Want the next Tenaya Therapeutics, Inc. earnings per share disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment Tenaya Therapeutics, Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.